Hemo Organic

{
  "main_header": {
    "sid": 322502,
    "name": "Hemo Organic",
    "stock_name": "Hemo Organic",
    "full_name": "Hemo Organic Ltd",
    "name_url": "stocks-analysis/hemo-organic",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "13.07",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "13.07",
    "mcapval": "5.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524590,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 67,
    "indexname": "India SENSEX",
    "isin": "INE422G01015",
    "curr_date": "Mar 19",
    "curr_time": "",
    "bse_nse_vol": "4.0 k",
    "exc_status": "Active",
    "traded_date": "Mar 19, 2026",
    "traded_date_str": "2026 03 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hemo-organic-322502-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Hemo Organic Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-hemo-organic-ltd-latest-results-good-or-bad-3837968",
        "imagepath": "",
        "date": "2026-02-13 19:34:33",
        "description": "Hemo Organic Ltd's latest financial results for Q2 FY26 reveal significant operational challenges. The company reported zero revenue for the second consecutive quarter, mirroring its performance in Q1 FY26, and incurred a net loss of ₹0.03 crores. This follows a brief period of profitability in Q4 FY25, where it recorded a profit of ₹0.37 crores on revenues of ₹2.41 crores, indicating that the recent lack of sales raises concerns about the sustainability of its business model.\n\nThe company's financial performance highlights a troubling trend of inconsistency, with only one profitable quarter out of the last seven. This pattern suggests a lack of a stable revenue-generating mechanism, as the company has struggled to maintain operational activity. The absence of meaningful sales and the accumulation of losses over the past quarters further underscore the operational distress faced by Hemo Organic.\n\nAdditional..."
      },
      {
        "title": "When is the next results date for Hemo Organic Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-hemo-organic-ltd-3833721",
        "imagepath": "",
        "date": "2026-02-11 23:16:17",
        "description": "The next results date for Hemo Organic Ltd is scheduled for 13 February 2026...."
      },
      {
        "title": "Hemo Organic Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hemo-organic-ltd-is-rated-sell-3771604",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/HemoOrganicLtd_mojoScore_3771604.png",
        "date": "2025-12-26 21:51:26",
        "description": "Hemo Organic Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with the latest insights into the company's performance and outlook."
      }
    ],
    "total": 187,
    "sid": "322502",
    "stock_news_url": "https://www.marketsmojo.com/news/hemo-organic-322502"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Thursday 26Th February 2026",
      "datetime": "26-Feb-2026",
      "details": "Outcome of Board Meeting held today i.e. Thursday 26th February 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Registered Office Address",
      "datetime": "26-Feb-2026",
      "details": "Intimation under regulation 30 (LODR) Regulation 2015 for Change in Registered Office Address",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of In-Principle Approval Received For Issue Of Convertible Warrants On Preferential Basis By Hemo Organic Limited (The Company) Under Regulation 28(1) Of The SEBI (LODR) Regulations 2015",
      "datetime": "17-Feb-2026",
      "details": "Intimation of In-Principle approval received for issue of convertible warrants on preferential basis.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Hemo Organic Ltd latest results good or bad?

2026-02-13 19:34:33

Hemo Organic Ltd's latest financial results for Q2 FY26 reveal significant operational challenges. The company reported zero revenue for the second consecutive quarter, mirroring its performance in Q1 FY26, and incurred a net loss of ₹0.03 crores. This follows a brief period of profitability in Q4 FY25, where it recorded a profit of ₹0.37 crores on revenues of ₹2.41 crores, indicating that the recent lack of sales raises concerns about the sustainability of its business model. The company's financial performance highlights a troubling trend of inconsistency, with only one profitable quarter out of the last seven. This pattern suggests a lack of a stable revenue-generating mechanism, as the company has struggled to maintain operational activity. The absence of meaningful sales and the accumulation of losses over the past quarters further underscore the operational distress faced by Hemo Organic. Additional...

Read full news article

When is the next results date for Hemo Organic Ltd?

2026-02-11 23:16:17

The next results date for Hemo Organic Ltd is scheduled for 13 February 2026....

Read full news article

Hemo Organic Ltd is Rated Sell

2025-12-26 21:51:26

Hemo Organic Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with the latest insights into the company's performance and outlook.

Read full news article

View All News